Abstract:Background Senile osteoporosis can cause bone fragility and increased risk for fractures and has been one of the most prevalent and severe diseases affecting the elderly population worldwidely. The underlying mechanisms are currently intensive areas of investigation. In age-related bone loss, decreased bone formation overweighs increased bone resorption. The molecular mechanisms underlying defective bone formation in age-related bone loss are not completely understood. In particular, the specific role of histone acetylation in age-related bone loss has not been examined thoroughly. Methods We employed 6- and 18-month-old mice to investigate the mechanisms of defective bone formation in age-related bone loss. Bone marrow stromal cells (BMSCs) were induced to undergo in vitro osteogenic differentiation. Chromatin immunoprecipitation (ChIP) was used to investigate the binding of histone deacetylases (HDACs) on Runx2 promoter in BMSCs. Luciferase reporter and transient transfection assay were employed to study Runx2 gene expression modulation by HDAC and androgen receptor (AR). siRNA and HDAC6 inhibitor, Tubastatin A, were used to inhibit HDAC6 in vitro. And systemic administration of Tubastatin A was used to block HDAC6 in vivo. Results Age-related trabecular bone loss was observed in 18-month-old mice compared with 6-month-old mice. In vitro osteogenic differentiation potential of BMSCs from 18-month-old mice was weaker than 6-month-old mice, in which there was Runx2 expression inactivation in BMSCs of 18-month-old mice compared with 6-month-old mice, which was attributable to HDAC6-mediated histone hypoacetylation in Runx2 promoter. There was competitive binding of HDAC6 and AR on Runx2 promoter to modulate Runx2 expression in BMSCs. More importantly, through siRNA- or specific inhibitor-mediated HDAC6 inhibition, we could activate Runx2 expression, rescue in vitro osteogenesis potential of BMSCs, and alleviate in vivo age-related bone loss of mice. Conclusion HDAC6 accumulation and histone hypoacetylation on Runx2 promoter contributed to the attenuation of in vitro osteogenic differentiation potential of BMSCs from aged mice. Through HDAC6 inhibition, we could activate Runx2 expression and osteogenic differentiation potential of BMSCs from aged mice and alleviate the age-related bone loss of aged mice. Our study will benefit not only for understanding the age-related bone loss, but also for finding new therapies to treat senile osteoporosis.

Histone Deacetylase 6 Promotes Skin Wound Healing by Regulating Fibroblast Migration and Differentiation in Aged Mice.

Downregulated SPESP1‐driven Fibroblast Senescence Decreases Wound Healing in Aged Mice

Declined Expression of Histone Deacetylase 6 Contributes to Periodontal Ligament Stem Cell Aging

Young fibroblast-derived exosomal microRNA-125b transfers beneficial effects on aged cutaneous wound healing

HDAC6 inactivates Runx2 promoter to block osteogenesis of bone marrow stromal cells in age-related bone loss of mice

Eif6 Modulates Skin Wound Healing by Upregulating Keratin 6B.

Histone deacetylase 6 controls cardiac fibrosis and remodelling through the modulation of TGF-β1/Smad2/3 signalling in post-infarction mice

TGFβ-mediated inhibition of hypodermal adipocyte progenitor differentiation promotes wound-induced skin fibrosis

The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice

Tissue Mechanics in Haired Murine Skin: Potential Implications for Skin Aging

757 Wound Healing in Aged Skin Exhibits Systems-Level Alterations in Cellular Composition and Cell-Cell Communication

Emerging Role of Dermal White Adipose Tissue in Modulating Hair Follicle Development During Aging

Age-Dependent Impairment of Hif-1 Alpha Expression in Diabetic Mice: Correction with Electroporation-Facilitated Gene Therapy Increases Wound Healing, Angiogenesis, and Circulating Angiogenic Cells

Selective Matrix-Hyaluronan Interaction with Cd44 and Rhogtpase Signaling Promotes Keratinocyte Functions and Overcomes Age-Related Epidermal Dysfunction

Cellular Mechanisms of Myofibroblast Differentiation and Dysfunctions in Wound Healing

Histone deacetylase 4 reverses cellular senescence via DDIT4 in dermal fibroblasts

Transforming Growth Factor-β Receptor-Mediated, p38 Mitogen-Activated Protein Kinase-Dependent Signaling Drives Enhanced Myofibroblast Differentiation during Skin Wound Healing in Mice Lacking Hyaluronan Synthases 1 and 3.

Deacetylation of MRTF-A by SIRT1 defies senescence induced down-regulation of collagen type I in fibroblast cells

miR-146a Decreases Inflammation and ROS Production in Aged Dermal Fibroblasts

Local and Transient Inhibition of P21 Expression Ameliorates Age-Related Delayed Wound Healing.

PRDX4 Improved Aging-Related Delayed Wound Healing in Mice.